Does Access to Housing Wealth Relax Liquidity Constraints for Entrepreneurs? Evidence from Sweden
Nordic Journal of Surveying and Real Estate Research · 04.03.2026 · 19 (1)
DOI: 10.30672/njsr.163282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nordic Journal of Surveying and Real Estate Research, online erschienen am 04.03.2026. Verfasst von Åsa Hansson. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liquidity constraints are often seen as a barrier to entrepreneurship, with many relying on personal or informal capital to start a business. This paper examines whether increased access to equity ─ via rising value of owner-occupied housing ─ affects the likelihood of business entry. Using detailed Swedish tax return data and exploiting the 2008 property tax reform as a natural experiment, we analyze how changes in house prices influence entrepreneurial activity. While higher housing prices correlate with business ownership and entry, this relationship disappears when isolating the causal effect of the tax reform. These findings contrast earlier findings and suggest that the value of owner-occupied housing proxy for individual characteristics rather than easing liquidity constraints, indicating that such constraints are not a major barrier to entrepreneurship in Sweden.
Zitieren
APA
Hansson, Å. (2026). Does Access to Housing Wealth Relax Liquidity Constraints for Entrepreneurs? Evidence from Sweden. Nordic Journal of Surveying and Real Estate Research, 19(1). https://doi.org/10.30672/njsr.163282
Vancouver
Hansson Å. Does Access to Housing Wealth Relax Liquidity Constraints for Entrepreneurs? Evidence from Sweden. Nordic Journal of Surveying and Real Estate Research. 2026;19(1). doi:10.30672/njsr.163282
BibTeX
@article{Hansson2026,
author = {Hansson, Åsa},
title = {Does Access to Housing Wealth Relax Liquidity Constraints for Entrepreneurs? Evidence from Sweden},
journal = {Nordic Journal of Surveying and Real Estate Research},
year = {2026},
volume = {19},
number = {1},
doi = {10.30672/njsr.163282}
}
EUVIMED